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Abstract
The growing incidence of non-melanoma skin cancer (NMSC) necessitates a thorough 
understanding of its primary risk factors, which include exposure to ultraviolet (UV) wavelengths 
of sunlight and age. Whereas UV radiation (UVR) has long been known to generate photoproducts 
in genomic DNA that promote genetic mutations that drive skin carcinogenesis, the mechanism by 
which age contributes to disease pathogenesis is less understood and has not been sufficiently 
studied. In this review, we highlight studies that have considered age as a variable in examining 
DNA damage responses in UV-irradiated skin and then discuss emerging evidence that the reduced 
production of insulin-like growth factor-1 (IGF-1) by senescent fibroblasts in the dermis of 
geriatric skin creates an environment that negatively impacts how epidermal keratinocytes respond 
to UVR-induced DNA damage. In particular, recent data suggest that two principle components of 
the cellular response to DNA damage, including nucleotide excision repair and DNA damage 
checkpoint signaling, are both partially defective in keratinocytes with inactive IGF-1 receptors. 
Overcoming these tumor-promoting conditions in aged skin may therefore provide a way to lower 
aging-associated skin cancer risk, and thus we will consider how dermal wounding and related 
clinical interventions may work to rejuvenate the skin, re-activate IGF-1 signaling, and prevent the 
initiation of NMSC.
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1. Introduction
Non-melanoma skin cancers (NMSCs) comprise the most common types of cancers in 
humans worldwide and originate from keratinocytes within the epidermal layer of the skin. 
In the United States alone, more than 2 million people are diagnosed with a NMSC each 
year [1,2]. The morbidity and high cost of treating NMSCs are a strain on both patients and 
the nation’s healthcare systems. These issues are particularly relevant for geriatric patients 
who make up the vast majority of NMSC cases [3] and who consume a high share of 
medical resources. Though there are a variety of approaches that can be employed to reduce 
NMSC incidence, novel interventions that are specifically targeted to older populations of 
people may therefore provide new and more effective ways of preventing skin 
carcinogenesis.
The single greatest risk factor for NMSC development is exposure to ultraviolet (UV) 
wavelengths of sunlight, which induce the formation of UV photoproducts in DNA. When 
not properly dealt with, these photoproducts may lead to mutations in genomic DNA that 
provide a growth advantage to epidermal keratinocytes and initiate a NMSC. The observed 
correlation between skin cancer and aging has traditionally been attributed to a lifetime of 
exposure to UVR that begins during childhood, which results in an accumulation of 
mutations that eventually drive tumorigenesis later in life. However, even in adults, sun 
avoidance and the application of sunscreens have been shown to reduce the incidence of 
actinic keratoses [4–6]. Thus, the initiation of UVR-induced carcinogenesis is not limited to 
youth and can occur throughout one’s lifetime. Nonetheless, the factors that affect the 
initiation of UV carcinogenesis may vary as a function of age. Indeed, the hypothesis that 
the altered physiology of geriatric skin may predispose keratinocytes in the epidermis to 
UVR-induced carcinogenesis has been considered and examined experimentally in recent 
years. In particular, the discoveries that the expression of insulin-like growth factor-1 
(IGF-1) is lower in the skin of geriatric individuals than in young adults and that the IGF-1/
IGF-1 receptor (IGF-1R) system regulates cellular responses to UVB has provided a 
paradigm shift in our understanding of aging-associated skin carcinogenesis [7,8].
In this review, we will therefore summarize how DNA photoproducts induced by UV 
wavelengths of light generate mutations in DNA and highlight the primary mechanisms by 
which cells respond to this DNA damage. This discussion will include an overview of 
nucleotide excision repair and DNA damage checkpoint signaling, which together allow 
cells to cope with a genome damaged by UV. Where appropriate, we will focus on published 
work that has addressed these issues in the context of aging and specifically within 
epidermal keratinocytes, which have the potential to become transformed and give rise to 
skin cancers. We will then review a growing body of literature that supports a role for the 
insulin-like growth factor (IGF-1) in keratinocyte responses to DNA damage and evidence 
that this system is de-regulated in geriatric skin. Lastly, we will discuss clinical interventions 
that can be employed to counteract this IGF-1-deficiency and the tumor-promoting 
environment of geriatric skin [9], which may provide a way to reduce skin carcinogenic risk 
in older patients.
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2. UV-Induced DNA Damage Formation, Repair, and Checkpoint Signaling
2.1. UV-Induced DNA Photoproduct Formation
Photons of light with wavelengths in the range of 100–400 nm fall within the UV spectrum, 
which can be further subdivided as UVA (320–400 nm), UVB (280–320 nm), or UVC (100–
280 nm) radiation. Though the sun emits UVR within all of these wavelengths, most UVC is 
absorbed by the Earth’s ozone layer. Thus, the UV wavelengths of sunlight that humans are 
typically exposed to on a daily basis are primarily composed of UVA (90%–95%) and UVB 
(5%–10%). A variety of cellular biomolecules absorb these wavelengths of light, including 
genomic DNA.
The direct absorption of UV photons by DNA induces the formation of adducts between 
adjacent pyrimidine nucleotides [10,11], with cyclobutane pyrimidine dimers (CPDs) and 
pyrimidine (6-4) pyrimidone photoproducts [(6-4)PPs] being the most abundant (Figure 1). 
A variety of factors, including DNA sequence context and the specific energy of the UVR, 
affect the relative induction of CPDs and (6-4)PPs following UV exposure. Much of our 
understanding of cellular responses to UVR have been derived from studies using UVC light 
sources, and thus some caution is warranted in extrapolating these findings to physiological 
exposures of human skin to sunlight. Nonetheless, though DNA absorbs UVB light less 
efficiently than UVC, both CPDs and (6-4)PPs are generated by UVB wavelengths of light. 
UVA is also capable of inducing CPD formation by direct photon absorption [12,13] and via 
a recently characterized process termed chemiexcitation, in which reactive oxygen and 
nitrogen species induced by UVA combine to excite electrons in fragments of melanin that 
ultimately induce CPD production in genomic DNA [14,15]. Thus, both CPDs and (6-4)PPs 
are caused by UVA and UVB wavelengths of sunlight and are thought be biologically 
relevant to human disease risk.
These UV photoproducts are problematic to irradiated cells because the DNA lesions are 
potentially mutagenic and/or lethal. For example, cytosines and 5-methylcytosines within 
CPDs spontaneously deaminate to uracils and thymines, respectively, at a million-fold 
increased rate relative to the undamaged nucleotides [16–19]. This deamination is thus 
thought to be a major cause of the UV signature C→T transitions that are often found in 
skin cancer-associated p53 gene mutations [20]. Moreover, (6-4)PPs and CPDs are physical 
barriers to the progression of DNA and RNA polymerases during the processes of DNA 
replication and transcription [21–23], respectively. Though specialized DNA polymerases 
exist that can introduce nucleotides opposite damaged template DNA, these so-called 
translesion (TLS) polymerases frequently do so in an error-prone manner [24–26]. 
Replication fork stalling due to polymerase blockage may also lead to strand breakage that 
can give rise to chromosomal abnormalities, including translocations [27–29]. Lastly, UV-
induced DNA damage can also cause cell death when essential gene products are unable to 
be transcribed by RNA polymerases and when stalled replication forks collapse to form 
catastrophic DNA double-strand breaks [23,30].
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2.2. Removal of UV Photoproducts by Nucleotide Excision Repair (NER)
Humans and other placental mammals possess a single system for removing UV 
photoproducts from genomic DNA known as nucleotide excision repair [31–33]. This repair 
system works by essentially cutting out the damaged bases from DNA in the form of a small 
DNA oligonucleotide approximately 30 nt in length. A schematic of NER is provided in 
Figure 2A. Depending on the mode of damage recognition, there are two ways in which 
NER can be initiated. In the transcription-coupled sub-pathway of NER (termed TC-NER), 
the stalling of an RNA polymerase at a UV photoproduct leads to the association of the 
Cockayne syndrome A and B proteins at the damage site, which then facilitate the 
recruitment of the core excision repair proteins that are necessary for damage excision. 
These factors include TFIIH (transcription factor II-H), RPA (replication protein A), and the 
XPA, XPF, and XPG proteins (xeroderma pigmentosum group A, F, and G). In contrast, in 
the global genomic repair pathway of NER (GG-NER) that operates throughout the genome, 
the damage recognition process requires XPC (xeroderma pigmentosum group C) instead of 
RNA polymerase. Nonetheless, regardless of the mechanism of damage recognition, the 
subsequent steps of NER are thought be identical and require the same five factors for 
damage excision. The multi-subunit protein factor TFIIH unwinds the DNA around the 
lesion to generate a repair bubble, and the XPA and RPA proteins facilitate the formation of 
a pre-incision complex that coordinates the actions of the structure-specific endonucleases 
XPF and XPG (XP group F and G), which cut the damaged strand of DNA at sites 
bracketing the lesion. This dual incision event therefore generates two reaction products, 
which include a small, single-stranded DNA (ssDNA) gap in the duplex DNA and a small, 
excised, damage-containing DNA oligonucleotide (sedDNA). The sedDNA is likely 
subsequently degraded by cellular nucelases, and the gap is filled in the by the actions of a 
DNA polymerase and ligase to complete the repair reaction [34].
Mutations in NER gene products give rise to both the disease xeroderma pigmentosum, 
which is characterized by a several thousand-fold increased risk of skin carcinogenesis, and 
to a neurodegenerative and premature aging disorder known as Cockayne syndrome [35,36]. 
Variations in NER gene product expression due to polymorphisms or other physiological 
factors within human populations are therefore expected to contribute to inter-individual 
differences in repair rates, skin aging, and in the propensity to develop skin cancers. 
Nonetheless, the removal of CPDs and (6-4)PPs by NER plays a critical role in preventing 
UV mutagenesis and maintaining cell and tissue viability following exposure to UVR.
2.3. Suppression of DNA Synthesis and Cell Cycle Progression by the DNA Damage 
Checkpoint
In addition to NER, cells have additional systems for detecting the presence of UV 
photoproducts throughout the genome that are thought to reduce the likelihood of 
introducing incorrect nucleotide opposite CPDs and (6-4)PPs during DNA replication and to 
provide additional time for damage removal by NER. These systems are termed DNA 
damage checkpoints and are comprised of protein kinases that regulate the activities of 
effector proteins that control DNA replication and cell cycle progression [37,38]. The two 
kinases most relevant to DNA replication-associated responses to UV-induced DNA damage 
are ATR (ataxia telangiectasia-mutated and rad3-related) and CHK1 (checkpoint kinase 1), 
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which act as a part of a coupled signaling network [39–41] to transiently suppress DNA 
synthesis in UV-damaged cells by delaying the entry of damaged G1 cells into S phase, 
preventing new initiation events at replication origins [29,42–47], and slowing replication 
fork progression in UV-irradiated cells that are already within S phase [29,48,49].
The two most well-recognized signals for activation of the ATR-CHK1 signaling network 
are unfilled gaps generated by NER that subsequently get enlarged by exonucleolytic action 
[50–52] and the uncoupling of DNA polymerase and helicase activities at replication forks 
[53] (Figure 2B). Interestingly, both of these processes generate a common DNA structure 
defined by a long stretch of ssDNA and a dsDNA/ssDNA primer-template junction [54]. The 
ssDNA is thought to become coated by RPA [55,56], which is major ssDNA-binding protein 
in human cells [57,58]. The binding of RPA to ssDNA likely prevents nucleases from 
inappropriately cutting the ssDNA and generating potentially more detrimental double-
stranded breaks in DNA. However, RPA also makes direct protein-protein contacts with 
numerous factors that facilitate the phosphorylation and activation of CHK1 by ATR. These 
interactions include associations with factors that recruit and activate both ATR and its 
canonical substrate CHK1. Thus, a number of studies have shown that RPA binding to the 
ATRIP (ATR-interacting protein) subunit of the ATR holoenzyme [59], the Rad9 component 
of the RHINO-9-1-1 clamp that is loaded onto the primer-template junction [60], and the 
ATR-activating TopBP1 and ETAA1 proteins [61–64] all play roles in promoting the 
activation of ATR. Similarly, through an interaction of RPA with the checkpoint mediator 
protein Tipin [65], CHK1 is recruited to ATR at sites of damage so that it can become 
phosphorylated and activated.
Once activated, ATR and CHK1 phosphorylate numerous protein targets that control DNA 
synthesis on UV-damaged templates [66–69]. Though the physiological significance of 
many of these substrates remains to be explored, some of the characterized checkpoint 
targets include the Cdc25 regulator of cyclin-dependent kinases (CDKs) necessary for S 
phase entry [70], the Treslin component of the replication initiation machinery [71–73], and 
additional factors important for replication fork elongation [74–79]. The relevance of this 
signaling pathway to the suppression of carcinogenesis is highlighted by studies showing 
that partial abrogation of ATR or CHK1 expression in mice increases the risk of 
tumorigenesis [39,80–82], including in the skin [83].
3. Effect of Aging on DNA Damage Responses in UV-Irradiated Human 
Epidermis
3.1. Effect of Age on UV Photoproduct Formation in the Epidermis
The process of aging can cause a number of changes to the morphology and physiology of 
skin [84–87], including a decrease in epidermal thickness and epidermal cell turnover. A 
decrease in the number of enzymatically active melanocytes in older individuals [88] may 
further contribute to a reduced ability of the epidermis to be protected from the induction of 
DNA damage by UV wavelengths of light. Thus, before examining how aging affects 
cellular responses to UV-induced DNA damage, it is important to understand how aging 
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impacts UV photoproduct formation in the epidermis of the skin. However, examination of 
this issue has been rather limited.
Nonetheless, one relevant study used the 32P-postlabeling method to quantify the induction 
and subsequent removal of a number of UV photoproducts from the epidermis of 30 human 
subjects of diverse age and skin type [89]. The methodology involved exposing previously 
unexposed participant buttock skin to 400 J/m2 of solar simulating radiation, excising a 
small punch biopsy of the area, and then purifying the genomic DNA from the epidermis. 
This genomic DNA was then treated with a panel of nucleases to produce nucleoside-3′-
phosphates that were subsequently 5′-labeled with T4 polynucleotide kinase and detected as 
trinucleotides (containing an unmodified 5′-thymidine) by high performance liquid 
chromatography. The use of photoproduct standards provided the investigators the means to 
quantify the abundance of TT<>T and TT<>C trinucleotides containing CPDs and (6-4)PPs 
within the subjects’ epidermal genomic DNA.
Interestingly, when the authors classified the subjects by age, the levels of all four of these 
adduct-containing damages were found to be higher in individuals over the age of 50 than in 
individuals under the age of 50 [89], though only the CPD-containing TT<>Cs reached a 
statistically significant difference. Nonetheless, using a multivariate regression analysis, the 
authors concluded that age was a more important factor than skin type in determining UV 
photoproduct levels and that aging one year caused an increase of roughly 1 CPD and 0.1 
(6-4)PP per 107 nucleotides. As will be discussed in greater detail below, several other 
studies that have addressed UV photoproduct levels in the epidermis as a function of subject 
age have typically only done so in the context of DNA repair and have not provided 
sufficient information regarding the levels of initial DNA damage caused by UV exposure. 
Consideration of this issue in future work may therefore provide a more complete picture 
regarding how skin aging affects both the generation of UV photoproducts and the 
subsequent cellular responses. The use of deep sequencing technologies such as Damage-seq 
[90] and related approaches to map UV photoproduct formation at specific genomic 
locations [91–95] would provide valuable information regarding how photoproduct 
induction across the genome changes as people age. It may also be advantageous to examine 
how proliferating keratinocytes in the basal layer of the epidermis, which are the cells that 
are capable of undergoing mutagenesis and transformation to give rise to skin tumors, are 
specifically affected by UV irradiation in aged skin.
3.2. Effect of Age on UV Photoproduct Repair in the Epidermis
Though there has long been interest in understanding the association between aging and the 
repair of UV photoproducts [96], many previous studies have yielded conflicting results and 
have been limited to fibroblasts or lymphocytes that were cultured and studied in vitro [97]. 
Measurements of UV photoproduct repair within the epidermis of the skin in situ may 
therefore be considered to be more physiologically relevant, and fortunately a number of 
studies have taken this approach. One such early investigation [98] exposed the skin of 
volunteers between the ages of 23 and 69 to 1 MED (minimal erythemal dose) of UV light 
with a sunlamp that emits wavelengths between 280 and 400 nm and then isolated the 
epidermis from punch biopsies at various time points following UV exposure. A classical 
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DNA repair assay utilizing the pyrimidine dimer-specific Micrococcus luteus UV-
endonuclease [99] was then employed to detect the presence and subsequent time-dependent 
loss of CPDs from epidermal genomic DNA. This report showed that whereas it took 
approximately 10.3 h for subjects within their 20 s to remove 50% of CPDs from genomic 
DNA, the same degree of CPD repair took 19.3 h among individuals over the age of 65 [98]. 
Thus, this study supported the concept that the removal of UV photoproducts is impaired in 
the skin of geriatric individuals relative to younger subjects.
In addition to quantifying DNA adduct levels immediately following UV exposure, the study 
employing the 32P-postlabeling and HPLC method described earlier [89] also examined the 
loss of the damaged nucleotides from epidermal genomic DNA at 24 and 48 h after 
irradiation. This study found that patients over the age of 50 had more CPD-containing 
TT<>T trinucleotides remaining in their epidermal genomic DNA 24 h after UV exposure 
than subjects under the age of 50, though this difference was no longer present by 48 h. 
However, this difference in photoproduct loss from genomic DNA was not observed for 
CPD-containing TT<>Cs. Thus, there may be some degree of sequence specificity regarding 
the repair of specific UV photoproducts that impact overall repair efficiency in the 
epidermis. In addition, because this study stratified patients into two rather broad groups that 
were either younger or older than 50 years of age, this limited data set may fail to adequately 
detect age-dependent changes in DNA repair.
Nonetheless, the notion that nucleotide excision repair of UV photoproducts occurs at a 
slower rate in the skin of older individuals was supported by a more recent study that 
compared CPD removal rates between subjects in their 20 s and 70 s, all of whom had a type 
III or IV skin type [100]. These authors used an anti-CPD antibody and both 
immunocytochemistry and immunoslot blot analysis of genomic DNA from the epidermis of 
the upper arm to quantify the loss of CPDs over the course of up to two weeks. Whereas 
CPDs were completely gone from the epidermis of the younger subjects within 4 days 
following exposure to 0.5 MED (with a light source that emits wavelengths between 275 and 
410 nm), approximately 50% of the CPDs remained in the epidermis of the skin at this time 
point in the geriatric individuals. In these older individuals, complete CPD removal took up 
to 2 weeks to take place. Whether or not this slower loss of CPDs was due solely to an NER 
defect, or also to reduced epidermal cell turnover was not determined.
The three studies described above examined the loss of UV photoproducts from whole 
epidermis. Though keratinocytes throughout the different layers of the epidermis will 
contain DNA damage following UV exposure, the effect of UV on the proliferating cells 
within the basal layer is potentially most relevant to skin carcinogenesis. Using anti-CPD 
and anti-Ki67 antibodies to stain replicating keratinocytes containing UV photoproducts, a 
more recent study showed that whereas skin from subjects between the ages of 20 and 28 
years displayed very few replicating keratinocytes containing DNA damage 24 h after 
exposure to 350 J/m2 of UVB (indicative of complete CPD removal by nucleotide excision 
repair), geriatric skin from subjects >65 years of age displayed many such cells [8]. As will 
be described below, this abnormal response to UVB exposure in geriatric skin was found to 
be correlated with an increase in senescent fibroblasts in the dermis of the skin and with an 
abrogated production of insulin-like growth factor (IGF-1).
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Together, these several studies indicate that the efficiency by which epidermal keratinocytes 
in human skin are able to remove CPDs may decrease as people age. However, it should be 
noted that the different approaches for measuring CPD repair that were used in the studies 
above have a number of limitations that are relevant to UV-induced mutagenesis and skin 
carcinogenesis. The first issue is that these studies have generally focused on CPDs and 
ignored (6-4)PPs, which are also capable of introducing mutations into genomic DNA. 
Although (6-4)PPs are generally repaired at a much faster rate than CPDs, this repair largely 
takes place within the same time frame as the bulk of ATR-CHK1 signaling (during the first 
4 h post-UV). Thus, defects in (6-4)PP removal, ATR-CHK1 signaling, and in the 
suppression of chromosomal DNA synthesis after UV could in principle be associated with 
mutagenesis that gives rise to skin cancers. Furthermore, the accuracy of assays for 
measuring CPD removal, which in many studies takes place on the time scale of days, may 
be complicated by effects of cell proliferation, epidermal cell turnover, and apoptosis. These 
processes may dilute CPD content within genomic DNA in a DNA repair-independent 
manner, and this complication therefore affects the accuracy of CPD quantitation as a 
reliable measure of nucleotide excision repair capacity in the skin. Thus, the application of 
novel technologies, including assays that directly detect the sedDNA products of nucleotide 
excision repair [101–105], may be advantageous in the future for quantifying DNA repair 
capacity as a function of age following UV exposures and for correlating these factors to 
skin carcinogenic risk.
3.3. Effects of UVR on DNA Synthesis and DNA Damage Checkpoints in the Epidermis
Whereas a number of studies have explored UV photoproduct formation and repair in human 
skin in vivo, much less is known regarding the effects of UVR on epidermal keratinocyte 
DNA synthesis and DNA damage checkpoint signaling in human epidermis. Nonetheless, an 
early study employed tritiated thymidine injection into the skin of human subjects following 
UVR exposure to monitor how UVR affects both normal, chromosomal DNA replication 
and DNA synthesis associated with DNA repair [106]. These two types of replication have 
been classically defined by autoradiographic microscopy as cells with either heavy labeling 
throughout the cell or with sparse labeling at purported sites of DNA repair, respectively. 
Interestingly, the study observed that within 3–5 h after UV exposure, the percentage of 
basal keratinocytes undergoing chromosomal DNA synthesis decreased from approximately 
5% to 2.5%–2.8% [106]. By 24 h after UV exposure, the percentage of basal cells 
performing DNA replication recovered to the level of unirradiated skin. Thus, this apparent 
transient inhibition of DNA synthesis may represent an active in vivo DNA damage 
checkpoint similar to that reported in cultured cells exposed to UVR in vitro. Whether ATR 
and CHK1 are responsible for this inhibition of DNA synthesis in UV-irradiated human skin 
is not known. Though a recent study demonstrated that the canonical ATR-dependent 
phosphorylation of CHK1 can be observed within the epidermis of human skin explants 
exposed to UVR ex vivo [107], previous studies of ATR and CHK1 in the context of skin 
have been largely restricted to mouse models [83,108]. However, one study using human 
foreskin explants observed an increase in cyclin B-positive basal keratinocytes 24 h after a 
sub-erythemal dose of UVR, which is indicative of a G2 checkpoint [109]. Moreover, this 
study observed that the topical application of caffeine, which is a known inhibitor of ATR 
kinase activity [110], abrogated this UV-induced G2 checkpoint [109]. This finding suggests 
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that ATR may indeed play a role in cell cycle checkpoints in UV-irradiated skin. Thus, future 
analyses of ATR-CHK1 signaling and DNA synthesis in UV-irradiated human skin in vivo, 
and the examination of these responses as a function of patient age, may therefore provide 
new clues into the early events of UV skin carcinogenesis in humans.
4. Effect of Aging on Insulin-Like Growth Factor-1 (IGF-1) Production in the 
Skin
4.1. Epidermal Keratinocyte IGF-1 Receptor (IGF-1R) Activation Is Altered in Aged Skin
As the most abundant cell type in the epidermis, keratinocytes are the major target of UVR 
and are also the cell type of origin for the development of NMSCs. Though keratinocytes are 
capable of responding to UV in a cell autonomous manner, interactions of keratinocytes with 
other cell types within the skin are also expected to influence keratinocyte responses to 
UVR. An important goal of skin carcinogenesis research is therefore to understand how the 
physiological environment of the skin contributes to NMSC development. Given that many 
aspects of skin biology change as human age [84–86], an additional issue to consider is 
whether these changes affect the cellular response of keratinocytes to UV-induced DNA 
damage.
Through the regulation of various intracellular signaling pathways that control cell 
proliferation and other cellular phenotypes, growth factors play fundamental roles in general 
cell biology, including within the epidermis of the skin. Local paracrine signaling in 
particular may affect keratinocyte growth and response to exogenous stress. One such factor 
of relevance to the epidermis and its response to UV-induced DNA damage is insulin-like 
growth factor-1 (IGF-1). In human skin, keratinocytes express the IGF-1 receptor (IGF-1R) 
but do not produce IGF-1 [111–113]. Instead, the major provider of IGF-1 to epidermal 
keratinocytes are fibroblasts in the underlying dermis [111–113]. The stimulation of the 
IGF-1R by IGF-1 activates a variety of intracellular signaling pathways, including the 
PI3K/AKT and MAPK networks [114]. As dermal fibroblasts age in vitro and become 
senescent, their ability to produce IGF-1 becomes reduced [8,115,116]. This in vitro finding 
has physiological relevance in vivo, as both increases in fibroblast senescence and decreases 
in IGF-1 production have been observed in the skin of geriatric patients over the age of 65 
relative to the skin of younger subjects in their 20 s [116]. Consistent with the idea that 
dermal production of IGF-1 impacts the activation status of the IGF-1R in keratinocytes, an 
examination of IGF-1R phosphorylation as a measure of its activation revealed it to be 
decreased in epidermal keratinocytes of geriatric skin in comparison to that in young adult 
skin [8]. These differences between young adult and geriatric skin regarding dermal 
fibroblast and epidermal keratinocyte function are summarized in Figure 3, and will be 
described in more detail below.
4.2. The IGF-1/IGF-1R System Affects Cell Fate Following Exposure to UVR
Extensive DNA damage caused by UVR may lead cells to undergo either apoptosis or 
senescence [117,118]. Both of these processes limit the ability of damaged cells that 
potentially contain UVR-induced gene mutations from undergoing continued proliferation, 
which in the context of the epidermis may otherwise lead to tumorigenesis [119,120]. 
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Studies with primary neonatal foreskin keratinocytes cultured in vitro demonstrated that the 
specific inactivation of the IGF-1R via withdrawal of IGF-1 ligand from the culture medium 
predisposed UVB-irradiated cells to undergo apoptosis [8,121]. To mimic the physiological 
environment of the skin, additional in vitro experiments were carried out using conditioned 
medium from fibroblasts depleted of IGF-1 via RNA interference, from fibroblasts induced 
to undergo senescence via oxidative stress or serial passaging (which resulted in reduced 
IGF-1 expression), and from fibroblast-derived conditioned medium supplemented with anti-
IGF-1 antibody [8,122]. The use of each of these conditioned mediums failed to protect 
keratinocytes from undergoing apoptosis following exposure to high dose UVB. These 
results therefore validated the hypothesis that fibroblast-derived IGF-1 regulates keratinocyte 
responses to UVB and suggested that a reduction in IGF-1 expression by fibroblasts in 
geriatric skin may alter the fate of epidermal keratinocytes to UVB-induced DNA damage.
When UV-induced DNA damage is less extensive, cells may undergo a permanent growth 
arrest known as senescence [117,118]. These cells remain viable and can contribute to tissue 
integrity in vivo but are incapable of further cell division. Interestingly, when primary 
keratinocytes were exposed to senescence-inducing doses of UVB in vitro, cells that had 
been deprived of IGF-1 were found to be less likely to undergo senescence [8,123]. Co-
staining of these cells for CPDs and the proliferation marker Ki67 revealed that these cells 
continued to proliferate in vitro in the presence of DNA damage. Furthermore, this in vitro 
finding with cultured keratinocytes also held true in the context of the epidermis from 
geriatric skin that displayed reduced IGF-1 expression in vivo [8]. Thus, the epidermis from 
the UVB-irradiated skin of subjects greater than 65 years old were found to contain 
significantly more proliferating keratinocytes with unrepaired CPDs 24 h after UVB 
exposure than skin from individuals 20–28 years old [8], which instead possessed few such 
cells. To show that this response was dependent on IGF-1, recombinant IGF-1 was injected 
into the skin of geriatric patients prior to UVB exposure and was found to lead to a 
significant reduction in CPD+/Ki67+ double positive cells 24 h following irradiation of the 
skin. Thus, the presence of IGF-1 in the skin and active IGF-1Rs in keratinocytes therefore 
appear to be required to prevent keratinocytes with unrepaired CPDs within the basal layer 
of the epidermis from continuing to proliferate.
4.3. The Removal of UV-Induced CPDs Is Affected by IGF-1R Status in Human 
Keratinocytes
To better understand the link between IGF-1 and UV photoproduct removal in human 
keratinocytes, additional studies were recently carried out using primary and telomerase-
immortalized human adult or neonatal foreskin-derived keratinocytes that were cultured in 
vitro [122,124]. In these experiments, the rate of CPD removal from genomic DNA was 
monitored by either immunofluorescence microscopy or immunoslot blot analysis with anti-
CPD antibody under conditions in which the IGF-1R was inactivated by either direct IGF-1 
withdrawal [122,124], the use of a small molecule inhibitor of the IGF-1R [124], or 
fibroblast-conditioned medium supplemented with anti-IGF-1 antibody [122]. Regardless of 
the mode of IGF-1R inhibition, the rate of CPD removal was found to be significantly 
slowed. These in vitro findings were also expanded upon and confirmed through 
experiments with human skin ex vivo and in vivo [124]. Experiments with human 
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abdominoplasty skin treated topically with either DMSO vehicle or an IGF-1R inhibitor 
prior to UVB irradiation and the subsequent isolation of basal keratinocytes revealed that the 
removal of CPDs was partially abrogated when the IGF-1R was inhibited [124]. Moreover, 
human skin grafted onto the backs of SCID/NOD mice and treated topically with an IGF-1R 
inhibitor was shown to be associated with a high number of CPD+/Ki67+ basal 
keratinocytes 24 h after UVB exposure [124], which mimics the phenotype of geriatric skin 
in human subjects.
Studies with cultured keratinocytes in vitro demonstrated that disruption of IGF-1R 
signaling was associated with a reduction in the expression of the NER factors XPC and 
XPF/ERCC4 at both the level of mRNA and protein [124]. These findings indicate that de-
regulation of the IGF-1/IGF-1R system during aging may lead to reduced NER gene 
expression that subsequently prevents keratinocytes from efficiently removing UV 
photoproducts from genomic DNA. This altered rate of repair may therefore increase the 
risk of mutagenesis and skin carcinogenesis. Given that inter-individual variability in NER 
has long been thought to impact skin carcinogenic risk, it will therefore be interesting to 
determine whether the expression of XPC and XPF/ERCC4 is reduced in the epidermis of 
geriatric skin relative to the skin of younger individuals.
4.4. Disruption of ATR-CHK1 Kinase Signaling and the Suppression of DNA Synthesis in 
Keratinocytes with Inactive IGF-1Rs
Though nucleotide excision repair is a major system that protects keratinocytes from DNA 
damage and associated mutagenesis associated with UV exposures, it is not the only 
protective barrier to cancer initiation. Cells also possess various DNA damage signaling 
pathways that sense DNA damage and transiently arrest cell cycle progression and DNA 
synthesis to provide additional time for DNA repair. Together, DNA repair and DNA 
damage checkpoint signaling therefore limit mutagenesis and carcinogenesis. As described 
above, the ATR and CHK1 kinases play a major role in regulating these various DNA 
damage responses following UVB exposure, and partial disruption of their activities is 
linked to tumorigenesis [39,80–83].
Two recent studies have examined how the activation status of the IGF-1R affects ATR-
CHK1 signaling following UVB exposure in cultured keratinocytes [107,122]. Both studies 
reported a reduction in the phosphorylation of the canonical ATR substrate CHK1 after UVB 
exposure when the IGF-1R was inactivated by either IGF-1 withdrawal or pharmacological 
inhibition. The relevance of these findings to keratinocytes in intact human skin was further 
demonstrated in human skin explants treated with an IGF-1R inhibitor prior to UVB 
treatment ex vivo, and similarly demonstrated a reduction in UVB-induced CHK1 
phosphorylation. Because the ATR-CHK1 signaling pathway targets several components of 
the DNA synthesis machinery, BrdU immunodot blot analysis was used to monitor the 
kinetics of DNA replication following UVB exposure in cultured keratinocytes in vitro. To 
minimize mutagenesis, cells damaged by low, non-toxic doses of UV or related chemical 
carcinogens transiently suppress DNA synthesis for several hours before resuming a normal 
rate of DNA replication [29,42,44–47,125]. This response is known to be abrogated in cells 
with deficient ATR-CHK1 signaling [42,125]. Interestingly, and consistent with biochemical 
Kemp et al. Page 11
Molecules. Author manuscript; available in PMC 2018 February 26.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
analyses of the ATR-CHK1 signaling network, inhibition of the IGF-1R was shown to 
partially abrogate this suppression of DNA synthesis after UVB exposure in cultured 
keratinocytes [107]. This checkpoint disruption may lead to increased mutagenesis, and 
additional experiments will be necessary to test this hypothesis. Moreover, given that ATR 
signaling has been linked to several other DNA damage responses in UV-irradiated cells, 
including apoptosis [126–130], senescence [131,132], and nucleotide excision repair during 
S phase [133,134], it is possible that the previously reported defects in these processes in 
keratinocytes with an inactive IGF-1R may be due in part to altered ATR kinase signaling.
The observation that both nucleotide excision repair and ATR-CHK1 signaling are disrupted 
in keratinocytes with inactive IGF-1Rs indicates that both phenotypes may be caused by a 
single, common defect in DNA metabolism. Indeed, both systems utilize the ubiquitous 
DNA metabolic protein RPA, which plays critical roles in DNA replication, repair, and 
recombination [55–58]. In the context of the cellular response to UVR, RPA facilitates 
photoproduct recognition and coordinates the recruitment and/or enzymatic activities of a 
number of proteins during both nucleotide excision repair [58,135–147] and ATR-CHK1 
signaling [59–61,65]. Though RPA normally becomes enriched in the chromatin fraction of 
keratinocytes within an hour after DNA damage induction by UVB where it can carry out 
NER and checkpoint signaling, a recent study found that this response was partially 
disrupted when the IGF-1R was inactivated [107]. Furthermore, the basal level of chromatin-
associated RPA was observed to be elevated in IGF-1R inhibitor-treated cells prior to UVB 
exposure, which may indicate the presence of ssDNA due to endogenous replicative stress. 
Thus, imbalances in growth factor signaling may generate cellular stress that subsequently 
interferes with the ability of keratinocytes to properly respond to UV.
Though RPA is generally thought to be an abundant nuclear protein, the fact that it functions 
in so many diverse DNA metabolic processes may become problematic under conditions in 
which its availability becomes limiting. Consistent with this notion, several recent studies 
have suggested that “RPA exhaustion” is a frequent problem in cells undergoing extensive 
replicative stress [134,148–151], including following UV exposure. Thus, it is possible that 
an insufficient supply of RPA in keratinocytes stressed by IGF-1R inactivation may lower 
the pool of RPA available for NER and ATR-CHK1 signaling. However, this hypothesis 
awaits experimental validation.
5. Dermal Wounding as a Preventive Approach for NMSC
There has long been an interest in the use of cosmetic dermal rejuvenation approaches to 
create more youthful-appearing skin [152,153]. These rejuvenation methods are diverse and 
include approaches such as dermabrasion and fractionated laser resurfacing [154]. These 
skin rejuvenation therapies are thought to induce a wounding response in dermal fibroblasts 
that ultimately stimulates the production of new collagen synthesis by fibroblasts in the skin. 
Indeed, both dermabrasion and fractionated laser resurfacing have been shown to decrease 
the percentage of senescent fibroblasts in the skin and to result in an increase in collagen 
expression in geriatric skin [116,155].
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Given that an increase in dermal fibroblast senescence in geriatric skin relative to young skin 
is correlated with a decrease in the expression of IGF-1 [8], the effect of these dermal 
wounding strategies on IGF-1 expression has therefore been examined over the past few 
years. Importantly, both rejuvenation methodologies were shown to result in an increase in 
IGF-1 expression in the skin of geriatric subjects [116,155] (Figure 3, right panel). Clinical 
studies were therefore carried out to compare the response of non-rejuvenated and 
rejuvenated skin of geriatric subjects to UVB by examining the presence of proliferating 
(Ki67+) keratinocytes containing unrepaired CPDs 24 h after UV exposure. Interestingly, 
and similar to that observed in the skin of young individuals, regions of skin that were 
rejuvenated by dermabrasion or fractionated laser resurfacing displayed a near complete 
absence of CPD+/Ki67+ keratinocytes [116,155]. Whether these methods allow 
keratinocytes to better utilize additional protective DNA damage responses, such NER and 
the ATR-CHK1 checkpoint signaling cascade, is currently unknown. It will therefore be 
interesting to determine whether these rejuvenation strategies elevate the expression of XPC 
and XPF/ERCC4 [124] and promote proper RPA function and ATR-CHK1 signaling in 
proliferating keratinocytes [107]. As described above, the replication of UV-damaged DNA 
has the potential to introduce mutations that give rise to cancer. Thus, identifying all of the 
ways in which geriatric skin behaves differently than young skin in response to UVB and 
characterizing the processes that can be modulated by skin rejuvenation approaches may be 
useful for better understanding the origin of NMSCs.
Nonetheless, these novel findings suggest that wounding therapies have the potential to be 
useful in preventing the initiation of NMSCs in geriatric patients [9,156]. It will therefore be 
interesting to determine whether there are differences between non-rejuvenated and 
rejuvenated skin in the emergence of keratinocytes with UV signature mutations following 
repeated exposures to UVB light. Long-term follow-up of patients with regions of 
rejuvenated skin will therefore shed important insights on this issue.
6. Conclusions
The fact that the majority of NMSCs occur in patients over the age of 60 indicates that the 
physiology of aged skin may contribute to the risk of UVB-induced skin carcinogenesis. As 
summarized here, the skin of geriatric individuals is characterized by an increase in dermal 
fibroblast senescence and a corresponding decrease in IGF-1 production. This phenotype is 
associated with the decreased activation of the IGF-1R in epidermal keratinocytes and in 
altered cellular responses to UVB-induced DNA damage, including defects in UV 
photoproduct removal rate by NER, ATR-CHK1 kinase signaling, and in the suppression of 
DNA synthesis following UVB exposure. Together these altered responses to DNA damage 
increase the likelihood of mutagenesis and NMSC development. Fortunately, these negative 
outcomes may be counteracted by dermal wounding methods that rejuvenate the skin and 
restore the IGF-1/IGF-1R system to that found in young skin. Thus, dermal wounding has 
the potential to become a cost effective method for preventing NMSC initiation in aging 
populations.
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Figure 1. 
UV-induced photoproduct formation in DNA. The absorption of UV photons of light by 
adjacent pyrimidine nucleotides in DNA generates two major photoproducts, the pyrimidine 
(6-4) pyrimidone photoproduct [(6-4)PP] and the cyclobutane pyrimidine dimer (CPD). 
Though photoproduct formation between adjacent thymines is shown, (6-4)PPs and CPDs 
can also form to varying extents between adjacent cytosines and between cytosines and 
thymines.
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Figure 2. 
Schematic of nucleotide excision repair and the ATR-CHK1-mediated DNA damage 
checkpoint. (A) In nucleotide excision repair, UV photoproducts (denoted by T<>T and 
yellow triangles) are initially sensed through either the XPC-dependent global genome 
repair pathway or the CSA/CSB-dependent transcription-coupled repair pathway. Regardless 
of the mode of damage recognition, the TFIIH, RPA, and XPA function to verify the 
presence of the lesion and promote the assembly of the active repair machinery. The 
subsequent recruitment and incisions by the XPF and XPG endonucleases generate a ~30-nt-
long excision gap and a small (~30-nt-long), excised, damage-containing DNA 
oligonucleotide (sedDNA). Filling in of the gap by a DNA polymerase and ligase and 
degradation of the sedDNA completes the repair reaction. (B) Unfilled excision gaps and 
DNA polymerase stalling at UV lesions generate regions of ssDNA that become bound by 
RPA and dsDNA/ssDNA primer-template junctions. These structures lead to the assembly of 
an active ATR-CHK1 signaling complex comprised of the RHINO-9-1-1 clamp and the 
ATR-activator TopBP1. In addition, RPA promotes the recruitment of the adaptor proteins 
Timeless-Tipin and Claspin, which function to specifically allow ATR to phosphorylate 
CHK1. The activation of these kinases leads to phosphorylation of a multiple downstream 
targets, many of which transiently prevent DNA synthesis in cells with UV-induced DNA 
damage.
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Figure 3. 
Model for the effects of age and IGF-1 status on fibroblast and keratinocyte behavior in 
UVB-irradiated human skin. (Left panel) In young adult skin, dermal fibroblasts produce 
IGF-1, which leads to active IGF-1Rs on keratinocytes in the epidermis. Thus, when these 
keratinocytes are exposed to UVB, they carry out an appropriate response, which includes 
efficient nucleotide excision repair (NER), activation of ATR-CHK1 signaling, and the 
suppression of DNA synthesis. Together, this appropriate response is associated with a low 
susceptibility to NMSC initiation. (Middle panel) In contrast, in geriatric skin containing 
many senescent fibroblasts, the reduced production of IGF-1 leads to inactive IGF-1Rs in 
epidermal keratinocytes. Exposure of these cells to UVB leads to an inappropriate response 
that includes deficiencies in NER, ATR-CHK1 signaling, and in the suppression of DNA 
synthesis, which may culminate in mutagenesis and a higher susceptibility to initiate NMSC. 
(Right panel) Geriatric skin treated with dermal rejuvenation intervention behaves similar to 
that of young adult skin.
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